[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 28, Issue 3 (Scientific Journal of Kurdistan University of Medical Sciences 2023) ::
SJKU 2023, 28(3): 1-12 Back to browse issues page
Amygdalin may potentiate the effects of lapatinib on SK-BR-3 cancer cell death through increasing Bax expression
Bahman Moradi poodeh
Associate Professor, Department of Laboratory Sciences, Lahijan Branch, Islamic Azad University, Lahijan, Iran. , bmoradipoodeh@yahoo.com
Abstract:   (1229 Views)

Background and Aim: : HER-2 Positive breast cancer is one of the aggressive types of cancer and is resistant to chemotherapy drugs such as lapatinib .Amygdalin is a natural compound found in the seeds of fruits such as apricot, peache, apple and almond. In recent years, antitumor effects of amygdalin have been reported in different types of cancer cells. The present study aimed to investigate the cytotoxic effectes of amygdalin in combination with lapatinib, on cell viability and Bax expression in SK-BR-3 breast cancer cell line as a cell line with high expression of HER-2.
Material and Methods: After cell culture we evaluated the survival of SK-BR-3 cells by MTT after 48 hours of treatment with different concentrations of amygdalin and lapatinib alone and in combination. The pre-apoptotic Bax expression level was measured by western blot method.
Results: Amygdalin and lapatinib significantly decreased survival of SK-BR-3 cells in a dose-dependent manner. The simultaneous use of amygdalin with lapatinib showed that amygdalin enhanced the lethal effect of lapatinib. Also, amygdalin at the concentration of 10 mg/ml increased the effects of 200 nM lapatinib on the expression of Bax protein.
Conclusion: This study showed that the amygdalin-lapatinib combination could be effective for breast cancer patients with HER-2 overexpression. However, more studies are recommended to obtain more definitive results.
Keywords: Lapatinib, Amygdalin, Breast cancer, Bax promoter, SK-BR-3 cell line
Full-Text [PDF 763 kb]   (127 Downloads)    
Type of Study: Original Research | Subject: Molecular Medicine and Genetics
Received: 2022/07/31 | Accepted: 2022/11/7 | Published: 2023/07/31
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moradi poodeh B. Amygdalin may potentiate the effects of lapatinib on SK-BR-3 cancer cell death through increasing Bax expression. SJKU 2023; 28 (3) :1-12
URL: http://sjku.muk.ac.ir/article-1-7472-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 28, Issue 3 (Scientific Journal of Kurdistan University of Medical Sciences 2023) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4570